Navigation Links
Asthmatics May Be At Risk for Lung Disease In The Future

COPD refers to a group of diseases that affect the lungs, including emphysema and chronic bronchitis. COPD is characterized by permanent // lung damage and irreversible airflow limitation. With asthma, on the other hand, the airways become inflamed, causing airflow obstruction and difficulty breathing, but the damage to the lungs is not thought to be permanent. Plus, the symptoms of asthma can usually be relieved spontaneously or with medication.

Asthmatics may have reason to worry about future lung diseases. According to a 20-year study, it was found that adults with asthma may have an increased risk of developing chronic obstructive pulmonary disease. During the research it was observed that active asthmatics are 12-times more likely to develop COPD later in life than non-asthmatics. However, researchers did find a significant difference between active and inactive asthmatics -- those who were previously diagnosed with asthma but did not experience symptoms. Thus researchers say this suggests that an increased risk is only associated with those who currently have asthma.

According to researchers smoking has been described as the main risk factor for the development of COPD. However, less than 20 percent of cigarette smokers acquire COPD, suggesting that other factors convey significant additional risk.Thus minimizing asthmatics’ exposure to risk factors such as tobacco smoke and air pollution may delay disease progression to COPD. Some specialists also suggest that effective anti-inflammatory therapy at the onset of asthma may decrease the likelihood of developing COPD.

Page: 1

Related medicine news :

1. What happens when Asthmatics consume Aspirin?
2. Asthmatics at increased risk of lung cancer
3. Easing Fears Among Asthmatics
4. Biofeedback Found To Reduce Steroid Dependence In Asthmatics
5. Reducing Corticosteriod Use In Asthmatics
6. Vitamin C – Supplementation A Boon For Asthmatics
7. Asthmatics need to be on guard for Major Diseases
8. Asthmatics, it pays to quit smoking
9. New Zealand To Give More Choice Of Drugs To Asthmatics
10. Monoclonal Antibody Reduces Exacerbations in Asthmatics
11. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
Post Your Comments:

(Date:12/1/2015)... , ... December 01, 2015 , ... ... Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: ... enhancements at the Radiological Society of North America (RSNA) 2015 annual meeting through ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, ... in the United States. Clarity is a Superior Dual Wavelength Platform which combines ... single platform that is easy to own and operate. , For over a ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... SACC-GA and SACC-USA through membership and leadership since 2008. Gary Bruce, President ... SACC-USA . Gary has spent a significant amount of time in Sweden ...
(Date:12/1/2015)... ... December 01, 2015 , ... SonaCare Medical ... HSJ Acute Sector Innovation Award on November 18th. This prestigious award recognizes annually ... propose exciting enhancements to the medical landscape. , The UCLH team won the ...
(Date:11/30/2015)... ... 2015 , ... Trevor and Taylor Crabb have unveiled an exciting new ... represent the United States. This hybrid crowdfunding campaign is designed to provide ... in addition to offering corporate sponsors with some great marketing deliverables with the brothers ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015  AccuTEC Blades, ... a new corporate logo and brand identity program. ... design and engineering of bladed products where "the ... --> --> Serving manufacturers and ... and auto glass equipment, AccuTEC,s product lines include ...
(Date:12/1/2015)... of adjunctive metformin therapy does not improve glycemic outcomes in ... from T1D Exchange and funded by the ... measures of obesity, including weight and BMI. The results, published ... American Medical Association , are from the largest clinical trial ... obese adolescents with type 1 diabetes. recent ...
(Date:12/1/2015)... , Dec. 1, 2015 During ... in San Francisco, CA , ... to the coronary marketplace. During a satellite symposium, ... Stent Design to Minimize Restenosis", a renowned physician ... available Medinol NIRxcell™ CoCr Coronary Stent System and ...
Breaking Medicine Technology: